Gastroparesis
📧 Sign up to get email alerts when something new happens for Gastroparesis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-12-20FDA Approved: METOCLOPRAMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic metoclopramide hydrochloride tablet under an original application from Heritage Pharmaceuticals (d/b/a Avet Pharmaceu…
-
FDA approval · 2013-12-04FDA Approved: KIT FOR THE PREPARTION OF TECHNETIUM TC99M SULFUR COLLOID — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a kit used to prepare Technetium-99m sulfur colloid for nuclear medicine imaging.
-
FDA approval · 2013-09-19FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for METOCLOPRAMIDE from Teva Parenteral Medicines, Inc., for the approved generic product under ANDA…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers
This terminated clinical trial from the University of Florida evaluated quality of life issues for gastroparesis patients and their caregive…
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis [Phase 2]
Phase 2 trial update for TZP-102 evaluating treatment of symptoms in diabetic gastroparesis. Study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-19FDA Approved: METOCLOPRAMIDE — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA's original application for metoclopramide hydrochloride, a generic version of metoclopramide.
-
CLINICAL_TRIALS withdrawal · 2013-03-19Clinical Trial Update: The Use of Domperidone for Gastroparesis [Phase 3]
A Phase 3 clinical trial evaluating domperidone for gastroparesis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis [Phase 2]
Phase 2 trial evaluating erythromycin given before endoscopy in patients who had subtotal gastrectomy and are at high risk of gastric stasis…
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus [Phase 2]
Phase 2 trial assessing safety and efficacy of once-daily oral TZP-102 for gastroparesis in patients with diabetes mellitus; the study has c…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis [Phase 3]
Phase 3 clinical trial evaluating temporary gastric electrical stimulation for drug-refractory gastroparesis; the study completed and result…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Use of Pyridostigmine for Constipation in Diabetics [Phase 1, Phase 2]
Clinical trial update showing completed Phase 1/Phase 2 studies of pyridostigmine for constipation in diabetics, with results posted in 2012…
-
CLINICAL_TRIALS withdrawal · 2012-09-13Clinical Trial Update: Domperidone for Relief of Gastrointestinal Disorders [NA]
The clinical trial evaluating domperidone for relief of various gastrointestinal disorders has been terminated.
-
FDA approval · 2012-09-10FDA Approved: METOCLOPRAMIDE — Supplemental Application (Genus Lifesciences Inc.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Genus Lifesciences Inc., completing regulatory action for …
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: The Effect of Elemental Diet on Gastric Emptying [NA]
This completed clinical trial evaluated whether an elemental diet improves gastric emptying in patients with postprocedural delayed gastric …
-
FDA approval · 2012-03-14FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Chartwell Governmental & Specialty RX, LLC., signaling an …
-
FDA approval · 2012-03-08FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for metoclopramide from Ipca Laboratories Limited.
-
CLINICAL_TRIALS research · 2011-05-24Clinical Trial Update: Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms
A completed clinical trial update assessing patient understanding and cognitive debriefing of a daily diary capturing gastroparesis symptoms…
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients [Phase 2]
Phase 2 trial comparing methylnaltrexone and erythromycin to facilitate gastric emptying in patients with gastroparesis was terminated.
-
FDA label_change · 2011-02-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for metoclopramide, resulting in changes to the drug's labeling.
-
FDA approval · 2011-02-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (Genus Lifesciences Inc.)
FDA approved Genus Lifesciences' supplemental application for metoclopramide hydrochloride (metoclopramide), authorizing its generic product…
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus [Phase 4]
This update describes a Phase 4 trial evaluating Cisapride for improving gastroparesis symptoms in patients with diabetes, which has been te…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options [Phase 4]
A Phase 4 clinical trial evaluating cisapride for chronic gastroparesis after failure of other treatments was terminated.
-
FDA approval · 2010-11-18FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for REGLAN (metoclopramide hydrochloride) from ANI Pharmaceuticals, representing an approved regulat…
-
CLINICAL_TRIALS trial_result · 2010-07-19Clinical Trial Update: Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers [Phase 1]
This Phase 1 safety and pharmacokinetic study of C13-URA in healthy volunteers has completed. The trial record lists gastroparesis as the as…
-
FDA approval · 2010-06-03FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for metoclopramide from Teva Parenteral Medicines, Inc., updating the product's approval status as p…